Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India

BACKGROUND & AIMS: Availability of directly-acting antivirals (DAAs) has changed the treatment landscape of hepatitis C virus (HCV) infection. The high price of DAAs has restricted their use in several countries. However, in some countries such as India, generic DAAs are available at much cheape...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Rakesh, Chen, Qiushi, Goel, Amit, Seguy, Nicole, Pendse, Razia, Ayer, Turgay, Chhatwal, Jagpreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435174/
https://www.ncbi.nlm.nih.gov/pubmed/28520728
http://dx.doi.org/10.1371/journal.pone.0176503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435174/
https://www.ncbi.nlm.nih.gov/pubmed/28520728
http://dx.doi.org/10.1371/journal.pone.0176503

Ejemplares similares